Viral Gene Transfer Vectors Committee

The Viral Gene Transfer Vectors Committee develops educational sessions across therapeutic areas and stages of development. The main goal of the committee is to highlight the recent advances and challenges of using viral vectors to deliver therapeutic genetic material. The committee aims to design symposia that provide researchers with insights into leveraging different viral vector modalities (DNA & RNA viruses, replicative and non-replicative, commonly used & newly discovered). Areas of focus include practical considerations for academic and industry professionals, including emerging technologies, manufacturing/product quality, and safety and efficacy during non-clinical and clinical development.
Full NamePositionOrganizationTerm StartTerm End
Joseph M. Lee, PhDChairBristol Myers Squibb6/1/20265/31/202721546
Charles Pugh, PhDMemberKriya Therapeutics6/1/20255/31/202866426
Sara Kathleen Powell, PhDMemberUNC Chapel Hill6/1/20255/31/202846874
Christian J. Buchholz, PhDMemberPaul-Ehrlich-Institut6/1/20255/31/202825086
Andrew C. Wilber, PhDMemberSouthern Illinois University School of Medicine6/1/20195/31/202811964
Denis Phichith, PhDMemberRoche - Basel6/1/20255/31/202868055
Jianghui Wang, PhDMemberCentre for Eye Research Australia6/1/20265/31/202964913
Hanna P. Lesch, PhDMemberExothera6/1/20245/31/202724067
Xiaojun Liu, PhDMemberReciBioPharm6/1/20255/31/202862949
Kailei Ding GoodierMemberJohn Hopkins University6/1/20265/31/202982954
Quanyi Li, PhDMemberRoche6/1/20245/31/202754629
Mukesh Mayani, PhDMemberUltragenyx Pharmaceuticals6/1/20255/31/202840157
Eva Andres Mateos, PhDMemberEli Lilly and Company6/1/20245/31/202731812
Irina Rakotondramasy, MrsMemberFUJIFILM Irvine Scientific6/1/20255/31/202847640
Chunping Qiao, PhDMemberNovartis Gene Therapies6/1/20255/31/202818964
Jiten Doshi, PhDMemberPattern Bio6/1/20245/31/202754146
Danielle GaleStaff LiaisonASGCT6/1/20215/31/204535359